Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q4 2023 Earnings

29FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-56.25

-37.56

-18.87

-0.18

Details

Expected EPS

-0.727208

Actual EPS

-4.05

Surprise EPS

-3.32

Surprise Percent

+456.92%

Description

Spyre Therapeutics (SYRE) has reported earnings of -4.05 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.